Participants who were taking sulfonylureas, DPP-4 inhibitors, -glucosidase inhibitors or sodiumglucose cotransporter-2 inhibitors as adjuncts to metformin were eligible for the study after a washout period of 28 days
Patients with these conditions should pursue coverage through their regular Part D plan
Foundayo: nausea, constipation, diarrhea, vomiting, indigestion, stomach (abdominal) pain, headache, swollen belly, feeling tired, belching, heartburn, gas, hair loss
For those considering this option, understanding the science and potential benefits can help in making informed decisions and achieving lasting health goals
*Cash pay pricing is subject to change based on availability
Heres a comprehensive guide on how to take BPC 157, brought to you by our team of experts